Younger people face growing risk for colorectal cancer, more advanced disease at diagnosis

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

After Karen Knudsen departed from the American Cancer Society late last year, the question of where she will end up becoming the fodder for cocktail party chatter throughout oncology.

CRUK and partners pledge £5.5m funding for colorectal cancer research

Cancer Research UK and partners on March 31 committed £5.5 million in funding to form a research team tasked with making personalized medicine a reality for people with colorectal cancer. The initiative is designed to unite research expertise and solve unanswered questions about the disease.

April 04, 2025

Vol.51 No.13

Drugs & Targets

Exact Sciences launches the Cologuard Plus test for colorectal cancer screening

Exact Sciences Corp. announced the launch of Cologuard Plus, the most accurate noninvasive colorectal cancer screening test reported in studies to date. FDA-approved for average-risk patients 45+ and covered by Medicare, the Cologuard Plus test detects 95% of colorectal cancers at 94% specificity in the U.S. screening population.

April 04, 2025

Vol.51 No.13

Clinical Roundup

Pandemic caused temporary disruptions in CRC screening and minimal impact on diagnosis, two studies show

Two recent studies by researchers from Regenstrief Institute and the Indiana University School of Medicine explore the effect of the pandemic on colorectal cancer screening tests and diagnostic colonoscopies in central Indiana.

March 28, 2025

Vol.51 No.12

In Brief

UA research team receives $1.2M ACS grant to study link between neighborhood environment and cancer risk

A University of Arizona Mel and Enid Zuckerman College of Public Health researcher has received a $1.2 million grant from the American Cancer Society to evaluate potential links between the neighborhood environment and cancer risk.

March 21, 2025

Vol.51 No.11

In Brief

W. Kimryn Rathmell awarded the ACS 2025 Medal of Honor

Former NCI Director W. Kimryn Rathmell was awarded the American Cancer Society 2025 Medal of Honor.

March 14, 2025

Vol.51 No.10

Younger people face growing risk for colorectal cancer, more advanced disease at diagnosis

YOU MAY BE INTERESTED IN

Karen Knudsen tells us why she took the CEO job at the Parker Institute for Cancer Immunotherapy

CRUK and partners pledge £5.5m funding for colorectal cancer research

Exact Sciences launches the Cologuard Plus test for colorectal cancer screening

Pandemic caused temporary disruptions in CRC screening and minimal impact on diagnosis, two studies show

UA research team receives $1.2M ACS grant to study link between neighborhood environment and cancer risk

W. Kimryn Rathmell awarded the ACS 2025 Medal of Honor

Renew today!

Subscriber content